FDA Clears New, Rapid-Acting Magnet Therapy for Treatment-Resistant Depression
In October 2021, researchers from the Stanford University School of Medicine published a study demonstrating the effectiveness of a new, rapid-acting magnet therapy on patients with treatment-resistant depression. SAINT, or Stanford accelerated intelligent neuromodulation therapy, is a more intensive and individualized iteration of transcranial magnetic stimulation (TMS), which has been in use for years. This […]
FDA Clears New, Rapid-Acting Magnet Therapy for Treatment-Resistant Depression Continue Reading »